Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Shares Issued (2020 - 2022)

Historic Shares Issued for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $140000.0.

  • Atea Pharmaceuticals' Shares Issued fell 8238.99% to $140000.0 in Q3 2022 from the same period last year, while for Dec 2022 it was $363000.0, marking a year-over-year decrease of 7522.18%. This contributed to the annual value of $267000.0 for FY2024, which is 389.11% up from last year.
  • Atea Pharmaceuticals' Shares Issued amounted to $140000.0 in Q3 2022, which was down 8238.99% from $223000.0 recorded in Q1 2022.
  • In the past 5 years, Atea Pharmaceuticals' Shares Issued registered a high of $317.6 million during Q4 2020, and its lowest value of $57000.0 during Q2 2021.
  • Moreover, its 3-year median value for Shares Issued was $223000.0 (2022), whereas its average is $45.6 million.
  • Its Shares Issued has fluctuated over the past 5 years, first crashed by 9995.53% in 2021, then plummeted by 5265.39% in 2022.
  • Quarter analysis of 3 years shows Atea Pharmaceuticals' Shares Issued stood at $317.6 million in 2020, then tumbled by 99.96% to $142000.0 in 2021, then fell by 1.41% to $140000.0 in 2022.
  • Its Shares Issued was $140000.0 in Q3 2022, compared to $223000.0 in Q1 2022 and $142000.0 in Q4 2021.